[Hypophyseal, thyroid and adrenal cortical functions in infections in newborn infants].

O. B. Chechkova,A. Ametov,N. Kisliak,G. Samsygina,A. Romanenko

Abstract:

What problem does this paper attempt to address?

New Strategies for Cysteine Bioconjugation and Protein Cross-Linking

Nafsika Forte

2018-08-28

Abstract:The connection of two or more proteins with different binding specificities or activities can lead to unique and powerful systems with significant potential in therapeutic applications, particularly oncology. While a plethora of active bifunctional proteins have been produced by fusion, this approach is not always viable, since modification of the N- or C- terminus can compromise the proteins’ bioactivities, with complications during folding and processing often being observed. Chemical cross-linking can offer a more versatile strategy towards the synthesis of protein-protein conjugates. However, current state-of-the-art approaches are either not selective, yielding heterogeneous mixtures or require mutations with natural or unnatural amino acids, which are often associated with low expression yields and limited applicability towards all protein systems. Recently, a bis-dibromomaleimide cross-linking reagent was used to create a bispecific scFv-Fab antibody in a site-specific manner, by targeting and bridging disulfide bonds. In this work, the application of these cross-linking reagents was extended into the conjugation of proteins containing different reactive handles, as well as sterically hindered conjugation sites. Diiodo-maleimides were shown to offer the ideal properties of rapid bioconjugation and importantly, reduced hydrolysis, which was identified as a significant factor affecting the conjugation efficiency. The optimized linkers were exploited to link human serum albumin to antibody fragments (scFv and Fab) as a prospective half-life extension platform, with retention of antigen binding and robust serum stability. The linker design was also extended to incorporate a third point of attachment for another biomolecule. An anti-CEA scFv homotrimer was formed, by disulfide bridging, which was shown to infer a combination of greater antigen avidity and increased in vivo half-life. Finally, with the view to developing a Bispecific T-cell Engager (BiTE) construct that could lead to more efficient cell-killing, an anti-CEA/ anti-CD3 scFv heterotrimer of increased avidity towards CD3 antigen was developed, showing the potential of this strategy for the construction of a diverse range of bioconjugates. The last part of this thesis describes investigations towards the development of a new methodology that selectively modifies specific lysine residues, via acyl transfer from the disulfide bond of Fab antibody fragment. This approach is expected to complement disulfide bridging as a strategy for selective modification, but also be advantageous for systems where this could result in detrimental changes to the antibody structure, offering a highly promising platform for bioconjugation.

Chemistry,Medicine
Improving the Stability of Maleimide–Thiol Conjugation for Drug Targeting

Marianne Lahnsteiner,Alexander Kastner,Josef Mayr,Alexander Roller,Bernhard K. Keppler,Christian R. Kowol

DOI: https://doi.org/10.1002/chem.202003951

2020-10-27

Abstract:Maleimides are essential compounds for drug conjugation reactions via thiols to antibodies, peptides and other targeting units. However, one main drawback is the occurrence of thiol exchange reactions with e.g. glutathione resulting in loss of the targeting ability. A new strategy to overcome such retro‐Michael exchange processes of maleimide‐thiol conjugates by stabilization of the thiosuccinimide via a transcyclization reaction is presented. This reaction enables the straightforward synthesis of stable maleimide‐thiol adducts essential in drug‐conjugation applications.
Maleimide–thiol adducts stabilized through stretching

Wenmao Huang,Xin Wu,Xiang Gao,Yifei Yu,Hai Lei,Zhenshu Zhu,Yi Shi,Yulan Chen,Meng Qin,Wei Wang,Yi Cao

DOI: https://doi.org/10.1038/s41557-018-0209-2

IF: 24.274

2019-02-04

Nature Chemistry

Abstract:Maleimide–thiol reactions are widely used to produce protein–polymer conjugates for therapeutics. However, maleimide–thiol adducts are unstable in vivo or in the presence of thiol-containing compounds because of the elimination of the thiosuccinimide linkage through a retro-Michael reaction or thiol exchange. Here, using single-molecule force spectroscopy, we show that applying an appropriate stretching force to the thiosuccinimide linkage can considerably stabilize the maleimide–thiol adducts, in effect using conventional mechanochemistry of force-accelerated bond dissociation to unconventionally stabilize an adjacent bond. Single-molecule kinetic analysis and bulk structural characterizations suggest that hydrolysis of the succinimide ring is dominant over the retro-Michael reaction through a force-dependent kinetic control mechanism, and this leads to a product that is resistant to elimination. This unconventional mechanochemical approach enabled us to produce stable polymer–protein conjugates by simply applying a mechanical force to the maleimide–thiol adducts through mild ultrasonication. Our results demonstrate the great potential of mechanical force for stimulating important productive chemical transformations.

chemistry, multidisciplinary
HbA1c during pregnancy: its relationship to meal related glycaemia and neonatal birth weight in patients with diabetes.

R. Gandhi,J. Brown,and G. Simm,Renee C. Page,I. Idris

DOI: https://doi.org/10.1016/J.EJOGRB.2007.08.011

2008-05-01

Abstract:
N-propionyl thiosuccinimide linker upon hydrolysis becomes into a cleavable crosslinker by a gas phase metastable fragmentation and makes more reliable the conjugation sites identification.

Luis Javier González,Pablo Enmanuel Ramos,Satomy Pousa,Paulo Carvalho,Michel Batista,Rodrigo Soares Caldeira Brant,Hironobu Hojo,Alina Rodríguez Mallón,Vladimir Besada,Toshifumi Takao

DOI: https://doi.org/10.26434/chemrxiv-2024-80jqw

2024-01-24

Abstract:Maleimide thiol chemistry is widely used for the synthesis of conjugate vaccines and antibody-drug-conjugates. Proteolysis of a conjugate vaccine mainly generates linear and type 2 peptides (cross-linked peptides) with a thiosuccinimide linker and its stabilized forms (thiazine, and/or hydrolyzed thiosuccinimide). Type 2 peptides contain valuable information on the conjugation sites. Cleavable crosslinkers could make more reliable the conjugation sites identifications, but based on a different chemistry, they are used to study protein-protein interactions and not in the synthesis of bioconjugates. Hydrolysis not only stabilizes the thiosuccinimide linker, but also turns it into a cleavable crosslinker via a gas phase metastable fragmentation observed in MALDI- and ESI-MS/MS analysis. The carboxyl group in the hydrolyzed thiosuccinimide linker provides a mobile proton that destabilizes the nearest pseudopeptide bond and, through the rearrangement of a five-membered ring intermediate, yields two intense linker fragment ions named here as P+71 and C+98. Specific 18O-labeling of the hydrolyzed thiosuccinimide linker confirms that P+71 ion, has the epsilon amino group of Lys modified by a -alanine residue while C+98 ion has the Cys residue S-alkylated by a succinic anhydride molecule. P+71 and C+98 provide information on the molecular masses of the crosslinked peptides pair, decrease the number of unassigned signals in the MS/MS spectra; and their backbone fragment ions increased the sequence coverage and make more reliable the assignment of conjugation sites. Stepped HCD is the fragmentation method of choice because in a single MS/MS spectrum several linker fragment ions and bn/yn ions were observed.

Chemistry
In Situ Maleimide Bridging of Disulfides and a New Approach to Protein PEGylation

Felix F. Schumacher,Muriel Nobles,Chris P. Ryan,Mark E. B. Smith,Andrew Tinker,Stephen Caddick,James R. Baker

DOI: https://doi.org/10.1021/bc1004685

IF: 4.7

2011-01-27

Bioconjugate Chemistry

Abstract:The introduction of non-natural entities into proteins by chemical modification has numerous applications in fundamental biological science and for the development and manipulation of peptide and protein therapeutics. The reduction of native disulfide bonds provides a convenient method to access two nucleophilic cysteine residues that can serve as ideal attachment points for such chemical modification. The optimum bioconjugation strategy utilizing these cysteine residues should include the reconstruction of a bridge to mimic the role of the disulfide bond, maintaining structure and stability of the protein. Furthermore, the bridging chemical modification should be as rapid as possible to prevent problems associated with protein unfolding, aggregation, or disulfide scrambling. This study reports on an in situ disulfide reduction-bridging strategy that ensures rapid sequestration of the free cysteine residues in a bridge, using dithiomaleimides. This approach is then used to PEGylate the peptide hormone somatostatin and retention of biological activity is demonstrated.

chemistry, multidisciplinary,biochemistry & molecular biology, organic,biochemical research methods
Development of new thioester equivalents for protein chemical synthesis.

Ji-Shen Zheng,Shan Tang,Yi-Chao Huang,Lei Liu

DOI: https://doi.org/10.1021/ar400012w

IF: 24.466

2013-01-01

Accounts of Chemical Research

Abstract:The chemical synthesis of proteins provides synthetic chemists with an interesting challenge and supports biological research through the generation of proteins that are not produced naturally. Although it offers advantages, studies of solid phase peptide synthesis have established limits for this technique: researchers can only prepare peptides up to 50 amino acids in length in sufficient yields and purity. Therefore, researchers have developed techniques to condense peptide segments to build longer polypeptide chains. The method of choice for chemical synthesis of these longer polypeptides is convergent condensation of unprotected protein fragments by the native chemical ligation reaction in aqueous buffer. As researchers apply this strategy to increasingly difficult protein targets, they have needed to overcome diverse problems such as the requirement for a thiol-containing amino acid residue at the ligation site, the difficulty in synthesizing thioester intermediates under mild conditions, and the challenge of condensing multiple peptide segments with higher efficiency. In this Account, we describe our research toward the development of new thioester equivalents for protein chemical synthesis. We have focused on a simple idea of finding new chemistry to selectively convert a relatively "low-energy" acyl group such as an ester or amide to a thioester under mild conditions. We have learned that this seemingly unfavorable acyl substitution process can occur by the coupling of the ester or amide with another energetically favorable reaction, such as the irreversible hydrolysis of an enamine or condensation of a hydrazide with nitrous acid. Using this strategy, we have developed several new thioester equivalents that we can use for the condensation of protein segments. These new thioester equivalents not only improve the efficiency for the preparation of the intermediates needed for protein chemical synthesis but also allow for the design of new convergent routes for the condensation of multiple protein fragments.
Thiol-selective native grafting from polymerization for the generation of protein-polymer conjugates

Melina Feldhof,Sandro Sperzel,Lorand Bonda,Susanne Boye,Adam Braunschweig,Ulla I.M. Gerling-Driessen,Laura Hartmann

DOI: https://doi.org/10.1039/d4sc04818k

IF: 8.4

2024-09-20

Chemical Science

Abstract:Protein-polymer conjugates combine properties of biopolymers and synthetic polymers, such as specific bioactivity and increased stability, with great benefits for various applications from catalysis to biomedicine. Furthermore, polymer conjugation can mimic important posttranslational modifications of proteins such as glycosylation. There are typically two approaches to create protein-polymer conjugates: the protein is functionalized in advance with an initiator for a grafting-from method or a previously produced polymer is conjugated to the protein via a grafting-to method. In this study, we present a new approach that uses native proteins and allows for direct grafting-from using a thiol-induced, light-activated controlled radical polymerization (TIRP) that is initiated at thiols from specific cysteine residues of the protein. This straightforward method is employed to introduce polymers onto proteins and enzymes without any prior protein modifications, it works in aqueous buffer and maintains the protein's native structure and activity. The resulting protein-polymer conjugates exhibit high molar masses and low dispersities. We demonstrate the versatility of this approach by introducing different types of polymers such as hydrophilic poly(2-hydroxyethyl acrylate) (pHEAA), temperature-responsive poly(N-isopropylacrylamide) (pNIPAM) as well as glycopolymers mimicking the natural protein glycosylation and enabling selective interactions. We present successful combinations of the protein and polymer functions e.g., temperature-induced aggregation leading to an increase in enzyme activity and the introduction of artificial glycosylation inducing specific protein-protein cluster formation and giving straightforward access to glycosurfaces. Based on this straightforward, potentially scalable yet highly controlled synthesis of protein-polymer conjugates, various areas of applications are envisioned ranging from biomedicine to material sciences.

chemistry, multidisciplinary
A Versatile Chemo-Enzymatic Conjugation Approach Yields Homogeneous and Highly Potent Antibody-Drug Conjugates.

Ying Xu,Shijie Jin,Wenbin Zhao,Wenhui Liu,Ding Ding,Jie Zhou,Shuqing Chen

DOI: https://doi.org/10.3390/ijms18112284

IF: 5.6

2017-01-01

International Journal of Molecular Sciences

Abstract:The therapeutic efficacy of antibodies can be successfully improved through targeted delivery of potent cytotoxic drugs in the form of antibody-drug conjugates. However, conventional conjugation strategies lead to heterogeneous conjugates with undefined stoichiometry and sites, even with considerable batch-to-batch variability. In this study, we have developed a chemo-enzymatic strategy by equipping the C-terminus of anti-CD20 ofatumumab with a click handle using Sortase A, followed by ligation of the payload based on a strain-promoted azide-alkyne cycloaddition to produce homogeneous conjugates. The resulting antibody-drug conjugates fully retained their antigen binding capability and proved to be internalized and trafficked to the lysosome, which released the payload with a favorable efficacy in vitro and in vivo. Thus, this reported method is a versatile tool with maximum flexibility for development of antibody-drug conjugates and protein modification.
A simple methodology for the synthesis of heterotelechelic protein-polymer-biomolecule conjugates

Jingquan Liu,Huiyun Liu,Volga Bulmus,Lei Tao,Cyrille Boyer,Thomas P. Davis

DOI: https://doi.org/10.1002/pola.23902

2010-01-01

Abstract:A synthetic protocol for the preparation of hetero-biofunctional protein-polymer conjugates is described. A chain transfer agent, SS-bis (alpha,alpha'-dimethyl-alpha "-acetic acid) trithiocarbonate was functionalized with alpha,omega-pyridyl disulfide (PDS) groups, Subsequently, one of the PDS groups was covalently attached to bovine serum albumin (BSA) at the specific free thiol group on the cysteine residue through a disulfide linkage. The second PDS group remained intact, as it was found to be inaccessible to further BSA functionalization. The BSA-macro-reversible addition-fragmentation chain transfer (RAFT) agent was then used to prepare BSA-polymer conjugates via in situ polymerization of oligo (ethyleneglycol) acrylate and N-(2-hydroxypropyl) methacrylamide using an ambient temperature initiator, 4,4'-azobis [2,9-imidazolin-2-ethyl)propane] dihydrochloride in an aqueous medium. Sodium dodecyl sulphate polyacrylamide gel electrophoresis (SDS-PAGE) confirmed that the in situ polymerization occurred at the protein surface where the RAFT agent was attached and the molecular weights of the BSA-polymer conjugates were found to increase concomitantly with monomer conversion and polymerization time. After polymerization the remaining terminal PDS groups were then utilized to attach thiocholesterol and a flurophore, rhodamine B to the protein-polymer conjugates via disulfide coupling. UV-Vis and fluorescence analyses revealed that similar to 80% of the protein conjugates were found to retain integral PDS end groups for further attachment to free thiol-tethered precursors. (C) 2010 Wiley Periodicals, Inc. J Polym Sci Part A: Polym Chem 48: 1399-1405, 2010
Location-agnostic site-specific protein bioconjugation via Baylis Hillman adducts

Mudassir H. Mir,Sangeeta Parmar,Chhaya Singh,Dimpy Kalia

DOI: https://doi.org/10.1038/s41467-024-45124-2

IF: 16.6

2024-01-29

Nature Communications

Abstract:Abstract Proteins labelled site-specifically with small molecules are valuable assets for chemical biology and drug development. The unique reactivity profile of the 1,2-aminothiol moiety of N -terminal cysteines ( N -Cys) of proteins renders it highly attractive for regioselective protein labelling. Herein, we report an ultrafast Z -selective reaction between isatin-derived Baylis Hillman adducts and 1,2-aminothiols to form a bis-heterocyclic scaffold, and employ it for stable protein bioconjugation under both in vitro and live-cell conditions. We refer to our protein bioconjugation technology as B aylis H illman o rchestrated p rotein a minothiol l abelling (BHoPAL). Furthermore, we report a lipoic acid ligase-based technology for introducing the 1,2-aminothiol moiety at any desired site within proteins, rendering BHoPAL location-agnostic (not limited to N -Cys). By using this approach in tandem with BHoPAL, we generate dually labelled protein bioconjugates appended with different labels at two distinct specific sites on a single protein molecule. Taken together, the protein bioconjugation toolkit that we disclose herein will contribute towards the generation of both mono and multi-labelled protein-small molecule bioconjugates for applications as diverse as biophysical assays, cellular imaging, and the production of therapeutic protein–drug conjugates. In addition to protein bioconjugation, the bis-heterocyclic scaffold we report herein will find applications in synthetic and medicinal chemistry.

multidisciplinary sciences
Equimolar Cross-Coupling Using Reactive Coiled Coils for Stable Covalent Protein Assemblies

Bradley L. Pentelute,Hironori Takeuchi,Andrei Loas,Elee Shimshoni,Satish Gandhesiri

DOI: https://doi.org/10.26434/chemrxiv-2024-0tzp1

2024-06-12

Abstract:Biocompatible cross-coupling reactions enable the efficient covalent attachment of large biomolecules at near-stoichiometric ratios, ensuring the stability and integrity of the resulting products. We present an affinity-based peptide platform utilizing coiled coils containing reactive side chains for proximity-driven protein cross-coupling in the presence of a cross-linking agent. This platform supports both chemical synthesis and recombinant expression, using canonical amino acids to generate reactive affinity tags. Employing the E3/K3 coiled coil pair as a scaffold, we design four complementary coils with cysteine residues as cross-linking sites, achieving >90% conversion to stable, covalent heterodimeric coupling products using 3,4-dibromomaleimide. Equimolar mixtures of proteins with reactive coils at their termini yield near-quantitative heterodimeric cross-coupling products. The strategic selection of complementary coiled coil pairs and cross-linking agents enables orthogonal assembly of macromolecules with diverse architectures. This method offers a versatile approach for creating covalent, stable fusion proteins, enhancing their stability and functionality for applications in chemical biology, biotechnology, and medicine.

Chemistry
Dinitroimidazoles As Bifunctional Bioconjugation Reagents for Protein Functionalization and Peptide Macrocyclization

Qunfeng Luo,Youqi Tao,Wangjian Sheng,Jingxia Lu,Huan Wang

DOI: https://doi.org/10.1038/s41467-018-08010-2

IF: 16.6

2019-01-01

Nature Communications

Abstract:Efficient and site-specific chemical modification of proteins under physiological conditions remains a challenge. Here we report that 1,4-dinitroimidazoles are highly efficient bifunctional bioconjugation reagents for protein functionalization and peptide macrocyclization. Under acidic to neutral aqueous conditions, 1,4-dinitroimidazoles react specifically with cysteines via a cine-substitution mechanism, providing rapid, stable and chemoselective protein bioconjugation. On the other hand, although unreactive towards amine groups under neutral aqueous conditions, 1,4-dinitroimidazoles react with lysines in organic solvents in the presence of base through a ring-opening & ring-close mechanism. The resulting cysteine- and lysine-(4-nitroimidazole) linkages exhibit stability superior to that of commonly employed maleimide-thiol conjugates. We demonstrate that 1,4-dinitroimidazoles can be applied in site-specific protein bioconjugation with functionalities such as fluorophores and bioactive peptides. Furthermore, a bisfunctional 1,4-dinitroimidazole derivative provides facile access to peptide macrocycles by crosslinking a pair of cysteine or lysine residues, including bicyclic peptides of complex architectures through highly controlled consecutive peptide macrocyclization.
The New Salicylaldehyde S,S-Propanedithioacetal Ester Enables N-to-C Sequential Native Chemical Ligation and Ser/Thr Ligation for Chemical Protein Synthesis

Dong-Liang Huang,Ying Li,Jun Liang,Lu Yu,Min Xue,Xiu-Xiu Cao,Bin Xiao,Chang-Lin Tian,Lei Liu,Ji-Shen Zheng

DOI: https://doi.org/10.1021/jacs.0c01561

IF: 15

2020-01-01

Journal of the American Chemical Society

Abstract:The combination of distinct peptide ligation techniques to facilitate chemical protein synthesis represents one of the long-standing goals in the field. A new combination ligation method of N-to-C sequential native chemical ligation and Ser/Thr ligation (NCL-STL) is described for the first time. This method relies on the peptide salicylaldehyde S,S-propanedithioacetal (SALPDT)-ester prepared by a new 1,3-propanedithiol-mediated reaction. The peptide SALPDT-ester, which is compatible with NCL, can be fully activated by N-chlorosuccinimide (NCS)/AgNO3 in aqueous solution to afford peptide SAL-ester for use in the subsequent STL. The practicality of the combined NCL-STL method is illustrated by the synthesis of S-palmitoylated matrix-2 (S-palm M2) ion channel from Influenza A virus and S-palmitoylated interferon-induced transmembrane protein 3 (S-palm IFITM3). This approach expands the multiple-segments peptide ligation toolkit for producing important and complex custom-made protein samples by chemical protein synthesis.
A hydrolyzed N ‐propionylthiosuccinimide linker is cleaved by metastable fragmentation, increasing reliability of conjugation site identification in conjugate vaccines

Pablo E. Ramos‐Bermúdez,Satomy Pousa,Paulo Carvalho,Rodrigo Soares Caldeira Brant,Michel Batista,Hironobu Hojo,Hilda E. Garay,Abel Roscoe,Alina Rodríguez Mallón,Vladimir Besada,Toshifumi Takao,Luis Javier González

DOI: https://doi.org/10.1002/rcm.9859

IF: 2.586

2024-07-21

Rapid Communications in Mass Spectrometry

Abstract:Abstract RATIONALE Conjugation sites are a quality attribute of conjugate vaccines. Proteolysis of bioconjugates synthesized by maleimide–thiol chemistry generates type 2 peptides with a hydrolyzed thiosuccinimide linker containing information on the conjugation sites. A mass spectrometry (MS)‐cleavable linker could make the identification of conjugation sites by MS more reliable. METHODS Four synthetic type 2 peptides with a hydrolyzed thiosuccinimide linker were analyzed by matrix‐assisted laser desorption ionization (MALDI) MS/MS with and without collision gas. These peptides were also partially labeled with 18 O in the linker to confirm the proposed fragmentation mechanism. A conjugate vaccine with the hydrolyzed thiosuccinimide linker was reduced and S ‐alkylated, digested with trypsin and analyzed by liquid chromatography–MS/MS using collision‐induced dissociation (CID) and higher‐energy collisional dissociation (HCD) fragmentation methods at a normalized collision energy of 30. RESULTS A metastable fragmentation preferentially cleaves the newly formed pseudopeptide bond within the hydrolyzed thiosuccinimide linker of type 2 peptides to yield P + 71 and C + 98 ions. These ions make the assignment of conjugation sites more reliable. Partial 18 O‐labeling and MS/MS analysis confirmed the proposed structures. CID produces these ions as the two most intense signals more favorably than HCD. The latter also yields these ions, guarantees better sequence coverage and promotes other fragmentations in the linker. CONCLUSIONS Hydrolyzed thiosuccinimide linker is cleavable in MALDI and electrospray ionization MS/MS analysis by a gas‐phase metastable fragmentation. The resulting fragment ions (P + 71 and C + 98) make the identification of conjugation sites more reliable. These results could be extended to self‐hydrolyzing maleimides, which efficiently stabilize the thiosuccinimide linker upon hydrolysis, in antibody–drug conjugates.

spectroscopy,chemistry, analytical,biochemical research methods
Synthesis Of Maleimide-End-Functionalized Star Polymers And Multimeric Protein-Polymer Conjugates

Lei Tao,Catherine S. Kaddis,Rachel R. Ogorzalek Loo,Gregory N. Grover,Joseph A. Loo,Heather D. Maynard

DOI: https://doi.org/10.1021/ma901540p

IF: 5.5

2009-01-01

Macromolecules

Abstract:Protein-polymer conjugtes exhibit Superior properties 10 Unmodified proteins, generating a high demand for these materials in the fields of medicine, biotechnology, and nanotechnology Multimeric conjugates are predicted to Surpass the activity of monomeric conjugates Herein, we report a straightforward method to synthesize multimeric polymer conjugates Four-armed poly(N-isopropylacrylamade) (pNIPAAm) was synthesized by reversible addition-fragmentation chain transfer (RAFT) polymerization in the presence of a tetrafunctionalized trithiocarbonate chain transfer agent (CTA). The polymer molecular weight, architecture, and polydispersity index (PDI) were verified by gel permeation chromatography (GPC) dynamic light scattering gel permeation chromatography (DLS-GPC), and matrix-assisted laser desorption/ ionization time-of-flight (MALDI-TOF) mass spectrometry. This approach afforded well-defined polymers (PDI's < 1 06) and the ability to target various molecular weights. Malcimide functional groups were introduced at the chain ends by heating the polymers in the presence of a furna-protected azo-intiator. This allowed for site-specific conjugation of V131CT4 lysozyme to the polymers to generate multimeric protein- polymer conjugates MALDI-TOF mass spectrometry, electrospray ionization gas-phase electrophoretic mobility macromolecule analysis (ESI-GEMMA), gel electrophoresis, and liquid chromatogrpahy tandem mass spectrometry (LC-MS/MS) of the trypsin digests demonstrated that multimeric protein-polymer conjugates had formed. This simple strategy provides ready access to star protein-polymer conjugates for application in the fields of drug discovery, drug, and nanotechnology
An Enabling Peptide Ligation Induced by Thiol‐Salicylaldehyde Ester for Chemical Protein Synthesis

Cuicui Li,Wenge Ma,Kang Jin

DOI: https://doi.org/10.1002/advs.202408538

IF: 15.1

2024-10-25

Advanced Science

Abstract:A novel and powerful peptide ligation between peptide TSAL esters and peptides are reported bearing N‐terminal cysteine/penicillamine that enables effective coupling reactions even at the most sterically hindered Pro‐Val site. This new method will bring more opportunities and valuable options for the future convergent synthesis of otherwise unobtainable proteins. Chemical protein synthesis by amide‐forming ligation of two unprotected peptide segments offers an effective strategy for the preparation of protein derivatives that are not accessible through bioengineering approaches. Herein, an unprecedented chemical ligation between peptides with C‐terminal 2‐mercaptobenzaldehyde (thiol‐salicylaldehyde, TSAL) esters and peptides bearing N‐terminal cysteine/penicillamine is reported. Reactive peptide TSAL esters can be obtained from peptide hydrazides in an operationally simple and highly effective manner. This chemoselective peptide ligation enables the rapid production of N,S‐benzylidene acetal intermediates, which can readily be converted into native amide bonds even at sterically hindered junctions. In addition, the current method can be applied compatibly in concert with other types of ligations and subsequent desulfurization chemistry, thereby facilitating convergent protein synthesis. The effectiveness of this new method is also showcased by the total synthesis of proteins ubiquitin and hyalomin‐3 (Hyal‐3), the efficient synthesis of protein ubiquitin‐fold modifier 1 (UFM1) via a C‐to‐N sequential TSAL ester‐induced ligation strategy, and the chemical synthesis of protein Mtb CM through a combined strategy of Ser/Thr ligation and TSAL ester‐induced ligations.

materials science, multidisciplinary,nanoscience & nanotechnology,chemistry
Facile Access to Branched Multispecific Proteins

Aniekan Okon,Jinyi Yang,JoLynn B Giancola,Oscar J Molina,Jessica Sayers,Keith M Cheah,Yanfeng Li,Eric R Strieter,Ronald T Raines

DOI: https://doi.org/10.1021/acs.bioconjchem.4c00162

IF: 4.7

2024-06-17

Bioconjugate Chemistry

Abstract:Approaches that leverage orthogonal chemical reactions to generate protein-protein conjugates have expanded access to bespoke chimeras. Although the literature is replete with examples of the semisynthesis of bispecific proteins, few methods exist for the semisynthesis of protein conjugates of higher complexity (i.e., greater than two-protein fusions). The recent emergence of trispecific cell engagers for immune cell redirection therapies necessitates the development of chemical methods for the...

chemistry, multidisciplinary,biochemistry & molecular biology, organic,biochemical research methods
Next generation maleimides enable the controlled assembly of antibody–drug conjugates via native disulfide bond bridging

Felix F. Schumacher,João P. M. Nunes,Antoine Maruani,Vijay Chudasama,Mark E. B. Smith,Kerry A. Chester,James R. Baker,Stephen Caddick

DOI: https://doi.org/10.1039/c4ob01550a

2014-01-01

Org. Biomol. Chem.

Abstract:Highly homogeneous ADCs are generated by the efficient bridging of interchain disulfide bonds in trastuzumab, using next generation maleimides.
Assembling Branched and Macrocyclic Peptides on Proteins

Christoph Nitsche,Sven Ullrich,Santhanalaxmi Kumaresan,Marina Rahman,Bishvanwesha Panda,Richard Morewood

DOI: https://doi.org/10.26434/chemrxiv-2024-9vm9l

2024-12-11

Abstract:A two-step, biocompatible strategy enables site-specific generation of branched and macrocyclic peptide–protein conjugates. Surface-exposed cysteines on proteins are modified by a small bifunctional reagent at near-physiological pH, followed by cyanopyridine–aminothiol click reactions to create branched or macrocyclic peptide architectures. This method offers design strategies for next-generation protein therapeutics.

Chemistry

[Hypophyseal, thyroid and adrenal cortical functions in infections in newborn infants].

New Strategies for Cysteine Bioconjugation and Protein Cross-Linking

Improving the Stability of Maleimide–Thiol Conjugation for Drug Targeting

Maleimide–thiol adducts stabilized through stretching

HbA1c during pregnancy: its relationship to meal related glycaemia and neonatal birth weight in patients with diabetes.

N-propionyl thiosuccinimide linker upon hydrolysis becomes into a cleavable crosslinker by a gas phase metastable fragmentation and makes more reliable the conjugation sites identification.

In Situ Maleimide Bridging of Disulfides and a New Approach to Protein PEGylation

Development of new thioester equivalents for protein chemical synthesis.

Thiol-selective native grafting from polymerization for the generation of protein-polymer conjugates

A Versatile Chemo-Enzymatic Conjugation Approach Yields Homogeneous and Highly Potent Antibody-Drug Conjugates.

A simple methodology for the synthesis of heterotelechelic protein-polymer-biomolecule conjugates

Location-agnostic site-specific protein bioconjugation via Baylis Hillman adducts

Equimolar Cross-Coupling Using Reactive Coiled Coils for Stable Covalent Protein Assemblies

Dinitroimidazoles As Bifunctional Bioconjugation Reagents for Protein Functionalization and Peptide Macrocyclization

The New Salicylaldehyde S,S-Propanedithioacetal Ester Enables N-to-C Sequential Native Chemical Ligation and Ser/Thr Ligation for Chemical Protein Synthesis

A hydrolyzed N ‐propionylthiosuccinimide linker is cleaved by metastable fragmentation, increasing reliability of conjugation site identification in conjugate vaccines

Synthesis Of Maleimide-End-Functionalized Star Polymers And Multimeric Protein-Polymer Conjugates

An Enabling Peptide Ligation Induced by Thiol‐Salicylaldehyde Ester for Chemical Protein Synthesis

Facile Access to Branched Multispecific Proteins

Next generation maleimides enable the controlled assembly of antibody–drug conjugates via native disulfide bond bridging

Assembling Branched and Macrocyclic Peptides on Proteins